FY2023 EPS Estimates for Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Lowered by Leerink Partnrs
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities research analysts at Leerink Partnrs lowered their FY2023 earnings per share estimates for Xenon Pharmaceuticals in a report released on Monday, January 29th. Leerink Partnrs analyst M. Goodman now anticipates that the biopharmaceutical company will post earnings per share of ($2.87) for the year, down from […]
More Stories
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...